Oct 20 (Reuters) - Boiron SA BOIR.PA :
* Q3 REVENUE EUR 128.4 MILLION VERSUS EUR 117.7 MILLION YEAR
AGO
* IN Q4, SEES GROWTH IN SALES OF HOMEOPATHIC SPECIALITIES
AND
OTHER HEALTH PRODUCTS AS WINTER ILLNESSES RETURN
* IN Q4, SEES FURTHER FALL IN SALES OF NON-PROPRIETARY
HOMEOPATHIC
MEDICINES IN FRANCE
* FOR FY, SEES HIGHER REVENUE THAN IN 2021 IN ALL
GEOGRAPHIES AND
SIGNIFICANT RISE IN PROFITABILITY
Source text for Eikon: ID:nACT76813
Further company coverage: BOIR.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))